ASMB - CIK 0001426800
ASSEMBLY BIOSCIENCES, INC. (ASMB) reported revenue of $72.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $72.30M | +153.5% |
| FY 2024 | $28.52M | +298.2% |
| FY 2023 | $7.16M | - |
| FY 2022 | $0.00 | -100.0% |
| FY 2021 | $6.25M | -92.1% |
| FY 2020 | $79.11M | +395.6% |
| FY 2019 | $15.96M | +7.8% |
| FY 2018 | $14.80M | +64.1% |
| FY 2017 |
ASSEMBLY BIOSCIENCES, INC. (ASMB) reported revenue of $72.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, ASSEMBLY BIOSCIENCES, INC.'s revenue grew from $0.00 to $72.30M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $9.02M |
| - |
| FY 2016 | $0.00 | - |